Gainers
- Neurotrope, Inc. (NASDAQ:NTRP) shares jumped 114.5% to $3.11 after the company announced it was awarded $2.7 million in funding by the National Institute of Health to support the Phase 2 Alzheimer’s study.
- Genprex, Inc. (NASDAQ:GNPX) shares climbed 54.8% to $1.78 after climbing 219.44% on Tuesday.
- One Stop Systems, Inc. (NASDAQ:OSS) shares climbed 41.5% to $2.90 after the company issued Q4 and FY19 sales guidance above analyst estimates.
- Trillium Therapeutics Inc. (NASDAQ:TRIL) gained 19% to $3.32 on heightened volume.
- Express, Inc. (NYSE:EXPR) rose 17.7% to $4.8856 after the company narrowed its Q4 earnings forecast and announced plans to close 100 stores by 2022.
- CEL-SCI Corporation (NYSE:CVM) shares gained 14.5% to $14.12.
- Aethlon Medical, Inc. (NASDAQ:AEMD) rose 14.2% to $2.6350 after gaining 12.14% on Tuesday.
- Baudax Bio, Inc. (NASDAQ:BXRX) gained 13.6% to $8.00. Baudax Bio announced Feb. 20 PDUFA date for intravenous meloxica.
- Tarena International, Inc. (NASDAQ:TEDU) shares rose 13.2% to $3.78.
- LexinFintech Holdings Ltd. (NASDAQ:LX) shares jumped 12.4% to $16.43.
- Franklin Financial Network, Inc. (NYSE:FSB) gained 10.5% to $37.73. FB Financial Corporation announced a merger with Franklin Financial Network.
- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) shares rose 10.5% to $3.27.
- XPEL, Inc. (NASDAQ:XPEL) gained 10.4% to $16.99.
- Qutoutiao Inc. (NASDAQ:QTT) shares jumped 10.2% to $4.7053. Qutoutiao announced resignation of Director and CFO. Qutoutiao also filed prospectus supplement relating to resale from time to time of 5.9 million ADSs by selling shareholder.
- Exact Sciences Corporation (NASDAQ:EXAS) shares jumped 10% to $94.50. UBS analysts noted that companies with liquid biopsy tests for colon cancer screening will present at this week’s 2020 Gastrointestinal Cancers Symposium, but they still ‘lag well behind’ Exact’s Cologuard.
- Soligenix, Inc. (NASDAQ:SNGX) shares surged 10% to $2.63.
- Akcea Therapeutics, Inc. (NASDAQ:AKCA) gained 9.5% to $18.99. Akcea and Ionis reported topline Phase 2 results of AKCEA-APOCIII-L Rx.
- Navient Corp (NASDAQ:NAVI) rose 9.2% to $15.13 after the company reported better-than-expected Q4 EPS results.
- Virgin Galactic Holdings, Inc. (NYSE:SPCE) rose 9.1% to $18.88 after climbing 10.61% on Tuesday.
- Soleno Therapeutics, Inc. (NASDAQ:SLNO) shares surged 9% to $3.6484.
- NeoPhotonics Corporation (NYSE:NPTN) rose 8.5% to $9.31.
- Superior Industries International, Inc. (NYSE:SUP) gained 7.5% to $3.59.
- Moderna Inc (NASDAQ:MRNA) gained 7.5% to $22.50 after the company announced it is working with US health agencies to develop a vaccine for the Wuhan Coronavirus.
- Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP) rose 6.3% to $4.40 despite the company reporting a public offering of 21 million ADS at $4 per ADS.
- Ally Financial Inc (NYSE:ALLY) climbed 5.8% to $32.00 after the company reported better-than-expected Q4 financial results.
- BioNTech SE (NASDAQ:BNTX) shares rose 5% to $38.37 after climbing 10.13% on Tuesday.
- Tesla Inc (NASDAQ:TSLA) gained 4.5% to $571.94 after Wedbush analysts raised their price target on the stock from $370 to $550, citing strong expected deliveries amid China demand.
- ACM Research, Inc. (NASDAQ:ACMR) rose 4.3% to $44.51. Morgan Stanley initiated coverage on ACM Research with an Overweight rating and a $45 price target.
- International Business Machines Corporation (NYSE:IBM) shares rose 3.6% to $144.21 after the company reported better-than-expected fourth-quarter results. The company also issued fiscal year 2020 EPS guidance above analyst estimates.
Check out these big penny stock gainers and losers
Losers
- NanoViricides, Inc. (NYSE:NNVC) shares dipped 51.1% to $4.16 after rising 152.98% on Tuesday. NanoViricides priced 2.5 million share underwritten public offering of common stock at $3.00 per share.
- FuelCell Energy Inc (NASDAQ:FCEL) shares fell 24.7% to $2.17 after the company reported worse-than-expected Q4 results.
- Novavax, Inc. (NASDAQ:NVAX) shares fell 19.7% to $7.89 after the company filed for a $100 million mixed shelf offering.
- Alpha Pro Tech, Ltd. (NYSE:APT) fell 13.2% to $4.21 after surging 38.57% on Tuesday.
- ImmuCell Corporation (NASDAQ:ICCC) dipped 13% to $5.15.
- Lilis Energy, Inc. (NYSE:LLEX) fell 13% to $0.2350 after Stifel Nicolaus downgraded the stock from Buy to Hold.
- Costamare Inc. (NYSE:CMRE) dropped 10.1% to $9.30.
- NeuroMetrix, Inc. (NASDAQ:NURO) dropped 10.1% to $3.94.
- Hutchison China MediTech Limited (NASDAQ:HCM) fell 10% to $26.56.
- Lakeland Industries, Inc. (NASDAQ:LAKE) dropped 9.2% to $12.51.
- Canaan Inc. (NASDAQ:CAN) shares declined 8.6% to $5.21.
- Blueprint Medicines Corp (NASDAQ:BPMC) fell 8.2% to $73.19 after the company reported a proposed public offering of $325 million of shares of common stock.
- CounterPath Corporation (NASDAQ:CPAH) shares declined 8% to $2.30.
- Mereo BioPharma Group plc (NASDAQ:MREO) shares tumbled 7.8% to $2.00.
- Ocean Power Technologies Inc (NASDAQ:OPTT) fell 5.8% to $0.8301 after the company filed for a 5.4 million share common stock offering by selling shareholder.
- Plug Power Inc. (NASDAQ:PLUG) shares fell 5.6% to $4.08.
- Zions Bancorporation, National Association (NASDAQ:ZION) fell 5% to $47.48 after the company reported worse-than-expected Q4 results. Bank of America analysts today downgraded the company’s stock from Buy to Neutral.
